Research into T cell-based vaccines is ongoing, with promising developments. Scientists are exploring new vaccine platforms, such as mRNA vaccines and vector-based vaccines, which can better stimulate T cell responses. Personalized vaccines, which tailor the antigen to an individual's immune profile, are also being investigated to enhance efficacy.
